AIMS: The studyAIMed at comparing two methods for evaluating thymidinekinase TK in serum - an older RIA method and novel DiviTum - in patients with MM and MGUS, and also comparing them with biochemical markers and degree of activity evaluated by imaging methods 99mTc-MIBI scintigraphy and 18F-FDG PET/CT. METHODS: Serum thymidinekinase TK levels were evaluated by DiviTum and an RIA method (TK REA kit by Immunotech);The study analyzed correlation of TK activity in serum with biochemical markers reflecting activity of MM: β2-m, LDH, the ratio of kappa to lambda (κ/λ) free light chains and percentage of bone marrow plasma cells (BMPC). 99mTc-MIBI scintigraphy and 18F-FDG PET/CT were performed at the time of diagnosis. The degree of activity was expressed semiquantitatively. Scans were classified as 0 (normal activity), 1 (diffuse positivity) or 2 (focal positivity). RESULTS: We found a strong positive correlation between TK in serum evaluated by DiviTum and by TK REA.. The DiviTum analytic method extended the detection range and was able to detect higher levels of TK than the RIA method. DiviTum technique found positive correlation with β2-m (r = 0.497) and LDH (r = 0.502) and moderate positive correlation with BMPC (r = 0.368). Significantly higher TK values measured by TK REA and DiviTum in the group of patients with MM (stages I, II or III) than in those with MGUS. Increased TK levels were observed in MIBI- or PET/CT-positive patients. Analysis of repeated measurements of TK in serum during treatment of MM patients found a correlation between change in TK measured by DiviTum and LDH during treatment. CONCLUSIONS: Analysis revealed a significant correlation between TK in serum and LDH, β2-m and BMPC. Increased levels of TK in serum were observed in MIBI- or PET/CT-positive patients. Combination of positivity of imaging methods which can localize active tumor lesions and increased levels of TK in serum can have an impact on decision-making and optimization of the therapeutic approach.

Biovica AB Uppsala Science Park Uppsala Sweden

Department of Clinical Biochemistry University Hospital Olomouc

Department of Internal Medicine 3 Nephrology Rheumatology and Endocrinology University Hospital Olomouc Czech Republic

Department of Medical Biophysics and Institute of Molecular and Translational Medicine Faculty of Medicine and Dentistry Palacky University Olomouc

Department of Nuclear Medicine University Hospital Olomouc

Laboratory of Metabolomics Institute of Molecular and Translational Medicine Faculty of Medicine and Dentistry Palacky University Olomouc

000      

00000naa a2200000 a 4500

001      

bmc17006035

003      

CZ-PrNML

005      

20191108091039.0

007      

ta

008      

170210s2015 xr ad f 000 0|eng||

009      

AR

024    7_

$a 10.5507/bp.2014.008 $2 doi

035    __

$a (PubMed)24572488

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a xr

100    1_

$a Bačovský, Jaroslav $u Department of Internal Medicine III - Nephrology, Rheumatology and Endocrinology, University Hospital Olomouc, Czech Republic $7 xx0053311

245    10

$a Analysis of thymidine kinase serum levels by novel method DiviTum in multiple myeloma and monoclonal gammopathy of undetermined significance - comparison with imaging methods 99mTc-MIBI scintigraphy and 18F-FDG PET/CT / $c J. Bacovsky, M. Myslivecek, J. Minarik, V. Scudla, T. Pika, J. Zapletalova, P. Petrova, M. Bartkova, T. Adam, SJ. Gronowitz,

520    9_

$a AIMS: The studyAIMed at comparing two methods for evaluating thymidinekinase TK in serum - an older RIA method and novel DiviTum - in patients with MM and MGUS, and also comparing them with biochemical markers and degree of activity evaluated by imaging methods 99mTc-MIBI scintigraphy and 18F-FDG PET/CT. METHODS: Serum thymidinekinase TK levels were evaluated by DiviTum and an RIA method (TK REA kit by Immunotech);The study analyzed correlation of TK activity in serum with biochemical markers reflecting activity of MM: β2-m, LDH, the ratio of kappa to lambda (κ/λ) free light chains and percentage of bone marrow plasma cells (BMPC). 99mTc-MIBI scintigraphy and 18F-FDG PET/CT were performed at the time of diagnosis. The degree of activity was expressed semiquantitatively. Scans were classified as 0 (normal activity), 1 (diffuse positivity) or 2 (focal positivity). RESULTS: We found a strong positive correlation between TK in serum evaluated by DiviTum and by TK REA.. The DiviTum analytic method extended the detection range and was able to detect higher levels of TK than the RIA method. DiviTum technique found positive correlation with β2-m (r = 0.497) and LDH (r = 0.502) and moderate positive correlation with BMPC (r = 0.368). Significantly higher TK values measured by TK REA and DiviTum in the group of patients with MM (stages I, II or III) than in those with MGUS. Increased TK levels were observed in MIBI- or PET/CT-positive patients. Analysis of repeated measurements of TK in serum during treatment of MM patients found a correlation between change in TK measured by DiviTum and LDH during treatment. CONCLUSIONS: Analysis revealed a significant correlation between TK in serum and LDH, β2-m and BMPC. Increased levels of TK in serum were observed in MIBI- or PET/CT-positive patients. Combination of positivity of imaging methods which can localize active tumor lesions and increased levels of TK in serum can have an impact on decision-making and optimization of the therapeutic approach.

650    _2

$a dospělí $7 D000328

650    _2

$a senioři $7 D000368

650    _2

$a senioři nad 80 let $7 D000369

650    _2

$a biologické markery $x krev $7 D015415

650    _2

$a ženské pohlaví $7 D005260

650    _2

$a fluorodeoxyglukosa F18 $x farmakologie $7 D019788

650    _2

$a lidé $7 D006801

650    _2

$a mužské pohlaví $7 D008297

650    _2

$a lidé středního věku $7 D008875

650    _2

$a monoklonální gamapatie nejasného významu $x diagnostické zobrazování $x enzymologie $7 D008998

650    _2

$a mnohočetný myelom $x diagnostické zobrazování $x enzymologie $7 D009101

650    12

$a pozitronová emisní tomografie $7 D049268

650    _2

$a prognóza $7 D011379

650    _2

$a radioimunoanalýza $7 D011863

650    _2

$a radiofarmaka $x farmakologie $7 D019275

650    _2

$a thymidinkináza $x krev $7 D013937

650    12

$a počítačová rentgenová tomografie $7 D014057

655    _2

$a srovnávací studie $7 D003160

655    _2

$a časopisecké články $7 D016428

655    _2

$a práce podpořená grantem $7 D013485

700    1_

$a Mysliveček, Miroslav, $d 1946- $7 jn20000401824 $u Department of Nuclear Medicine, University Hospital Olomouc

700    1_

$a Minařík, Jiří $7 xx0106330 $u Department of Internal Medicine III - Nephrology, Rheumatology and Endocrinology, University Hospital Olomouc, Czech Republic

700    1_

$a Ščudla, Vlastimil, $d 1946- $7 jn20000402953 $u Department of Internal Medicine III - Nephrology, Rheumatology and Endocrinology, University Hospital Olomouc, Czech Republic

700    1_

$a Pika, Tomáš $7 xx0071238 $u Department of Internal Medicine III - Nephrology, Rheumatology and Endocrinology, University Hospital Olomouc, Czech Republic

700    1_

$a Zapletalová, Jana $7 xx0111614 $u Department of Medical Biophysics and Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University Olomouc

700    1_

$a Petrová, Pavla $7 xx0166833 $u Department of Clinical Biochemistry, University Hospital Olomouc; Laboratory of Metabolomics, Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University Olomouc

700    1_

$a Bartková, Margita, $d 1972- $7 xx0136364 $u Department of Clinical Biochemistry, University Hospital Olomouc

700    1_

$a Adam, Tomáš, $d 1965- $7 xx0054162 $u Department of Clinical Biochemistry, University Hospital Olomouc

700    1_

$a Gronowitz, Simon J. $u Biovica AB, Uppsala Science Park, Uppsala, Sweden

773    0_

$w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czech Republic $x 1213-8118 $g Roč. 159, č. 1 (2015), s. 135-138

856    41

$u http://biomed.papers.upol.cz/ $y domovská stránka časopisu

910    __

$a ABA008 $b A 1502 $c 958 $y 4 $z 0

990    __

$a 20170210 $b ABA008

991    __

$a 20191108091312 $b ABA008

999    __

$a ok $b bmc $g 1192565 $s 966682

BAS    __

$a 3

BAS    __

$a PreBMC

BMC    __

$a 2015 $b 159 $c 1 $d 135-138 $e 20140225 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606

GRA    __

$a NT12215 $p MZ0

GRA    __

$a NT14393 $p MZ0

LZP    __

$b NLK118 $a Pubmed-20170210